be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Show search box

2015-02-23

Tobacco or CHO? The race against time in production of Ebola cure ZMapp.

Tobacco or CHO? The race against time in production of Ebola cure ZMapp.

Both in terms of cost, ease of handling, as well as the efficiency of the process, tobacco is an attractive alternative to mammalian CHO cell line routinely utilized in biological and medical research for the production of antibodies. Will the classic beat innovation this time? The time may be critic... Read more

Tags protein , Ebola , CHO , tobacco

2014-08-26

How to stop Ebola?

How to stop Ebola?

According to the World Health Organization (WHO) the Ebola outbreak in West Africa is to date the worst one with more than 1,200 people dead because of the infection. Although the virus has been discovered approximately 40 years ago it is still extremely hard to manage as no effective cure or vaccine... Read more

Tags virus , Ebola , epidemic